BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Catella J, Bertoletti L, Mismetti P, Ollier E, Samperiz A, Soler S, Suriñach JM, Mahé I, Lorente MA, Braester A, Monreal M; for the investigators of the RIETE registry. Severe renal impairment and risk of bleeding during anticoagulation for venous thromboembolism. J Thromb Haemost 2020;18:1728-37. [DOI: 10.1111/jth.14837] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bertoletti L. Initial Anticoagulant Treatment of Pulmonary Embolism: How Can We Better Predict Bleeding in the Early Days Rather Than the Early Months? Chest 2021;160:1596-8. [PMID: 34743843 DOI: 10.1016/j.chest.2021.07.022] [Reference Citation Analysis]
2 Pływaczewska M, Jiménez D, Lankeit M, Pruszczyk P, Kostrubiec M. A Comparison of GFR Calculated by Cockcroft-Gault vs. MDRD Formula in the Prognostic Assessment of Patients with Acute Pulmonary Embolism. Dis Markers 2021;2021:6655958. [PMID: 34925647 DOI: 10.1155/2021/6655958] [Reference Citation Analysis]
3 Poenou G, Dimitru Dimitru T, Lafaie L, Mismetti V, Heestermans M, Bertoletti L. Factor XI Inhibition for the Prevention of Venous Thromboembolism: An Update on Current Evidence and Future perspectives. VHRM 2022;Volume 18:359-73. [DOI: 10.2147/vhrm.s331614] [Reference Citation Analysis]
4 Murgier M, Bertoletti L, Bikdeli B, Jimenez D, Trujillo-santos J, Merah A, de Ancos C, Fidalgo Á, Aibar J, Monreal M; RIETE Investigators. Prognostic impact of acute kidney injury in patients with acute pulmonary embolism data from the RIETE registry. J Thromb Thrombolysis. [DOI: 10.1007/s11239-022-02633-5] [Reference Citation Analysis]
5 Hobohm L, Anušić T, Konstantinides SV, Barco S. Ambulatory treatment of low-risk pulmonary embolism in fragile patients: a subgroup analysis of the multinational Home Treatment of Pulmonary Embolism (HoT-PE) Trial. Eur Respir J 2020;56:2000663. [DOI: 10.1183/13993003.00663-2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Goto S, Haas S, Ageno W, Goldhaber SZ, Turpie AGG, Weitz JI, Angchaisuksiri P, Nielsen JD, Kayani G, Farjat A, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE Investigators. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease. JAMA Netw Open 2020;3:e2022886. [PMID: 33112399 DOI: 10.1001/jamanetworkopen.2020.22886] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ghenassia-Fouillet L, Morel A, Frappé P, Le Hello C, Lerche V, Sevestre MA, Bertoletti L. Management of superficial venous thrombosis in unevaluated situations: Cancer, severe renal impairment, pregnancy and post-partum. Phlebology 2021;36:464-72. [PMID: 33407053 DOI: 10.1177/0268355520982456] [Reference Citation Analysis]
8 Murgier M, Fouillet L, Ollier E, Merah A, Moulin N, Accassat S, Duvillard C, De Magalhaes E, Mismetti P, Monreal M, Bertoletti L. Recovery from acute kidney injury in patients with pulmonary embolism: A single-center study. Thromb Res 2021;199:106-9. [PMID: 33485093 DOI: 10.1016/j.thromres.2020.12.020] [Reference Citation Analysis]